Cargando…
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a mu...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447361/ https://www.ncbi.nlm.nih.gov/pubmed/30942690 http://dx.doi.org/10.7554/eLife.45393 |
_version_ | 1783408492325896192 |
---|---|
author | Chou-Zheng, Lucy Hatoum-Aslan, Asma |
author_facet | Chou-Zheng, Lucy Hatoum-Aslan, Asma |
author_sort | Chou-Zheng, Lucy |
collection | PubMed |
description | CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a multi-subunit effector complex that destroys invading DNA and RNA. Here, we demonstrate that a model type III system in Staphylococcus epidermidis relies upon the activities of two degradosome-associated nucleases, PNPase and RNase J2, to mount a successful defense. Genetic, molecular, and biochemical analyses reveal that PNPase promotes crRNA maturation, and both nucleases are required for efficient clearance of phage-derived nucleic acids. Furthermore, functional assays show that RNase J2 is essential for immunity against diverse mobile genetic elements originating from plasmid and phage. Altogether, our observations reveal the evolution of a critical collaboration between two nucleic acid degrading machines which ensures cell survival when faced with phage attack. |
format | Online Article Text |
id | pubmed-6447361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-64473612019-04-05 A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity Chou-Zheng, Lucy Hatoum-Aslan, Asma eLife Microbiology and Infectious Disease CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a multi-subunit effector complex that destroys invading DNA and RNA. Here, we demonstrate that a model type III system in Staphylococcus epidermidis relies upon the activities of two degradosome-associated nucleases, PNPase and RNase J2, to mount a successful defense. Genetic, molecular, and biochemical analyses reveal that PNPase promotes crRNA maturation, and both nucleases are required for efficient clearance of phage-derived nucleic acids. Furthermore, functional assays show that RNase J2 is essential for immunity against diverse mobile genetic elements originating from plasmid and phage. Altogether, our observations reveal the evolution of a critical collaboration between two nucleic acid degrading machines which ensures cell survival when faced with phage attack. eLife Sciences Publications, Ltd 2019-04-03 /pmc/articles/PMC6447361/ /pubmed/30942690 http://dx.doi.org/10.7554/eLife.45393 Text en © 2019, Chou-Zheng and Hatoum-Aslan http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Microbiology and Infectious Disease Chou-Zheng, Lucy Hatoum-Aslan, Asma A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
title | A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
title_full | A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
title_fullStr | A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
title_full_unstemmed | A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
title_short | A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
title_sort | type iii-a crispr-cas system employs degradosome nucleases to ensure robust immunity |
topic | Microbiology and Infectious Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447361/ https://www.ncbi.nlm.nih.gov/pubmed/30942690 http://dx.doi.org/10.7554/eLife.45393 |
work_keys_str_mv | AT chouzhenglucy atypeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity AT hatoumaslanasma atypeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity AT chouzhenglucy typeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity AT hatoumaslanasma typeiiiacrisprcassystememploysdegradosomenucleasestoensurerobustimmunity |